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Jak2 Deficiency Defines an Essential
Developmental Checkpoint in Definitive
Hematopoiesis
It is now recognized that tyrosine kinases of the Janus
kinase (Jak) family play a pivotal role in signal transduc-
tion via cytokine receptors (Ihle et al., 1995). At present,
this family consists of the four mammalian members
Jak1, Jak2, Jak3, and tyk2 (Ihle, 1995). Jaks appear
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The function of Jaks was initially discovered by gener-
ating cell lines resistant to the effects of interferonsJanus kinases (Jaks) play an important role in signal
(IFNs). These defects could bereconstituted by express-transduction via cytokine and growth factor receptors.
ing different cDNAs encoding for Jaks (Darnell et al.,A targeted inactivation of Jak2 was performed. Jak22/2
embryos are anemic and die around day 12.5 postcoi- 1994). It was shown that cellular responses to IFNa re-
tum. Primitive erythrocytes are found, but definitive quire Jak1 and tyk2, whereas a response to IFNg re-
erythropoiesis is absent. Compared to erythropoietin quires Jak1 and Jak2 (Velazquez et al., 1992; MuÈ ller et
receptor±deficient mice, the phenotype of Jak2 defi- al., 1993; Silvennoinen et al., 1993a, Watling et al., 1993).
ciency is more severe. Fetal liver BFU-E and CFU-E More recent findings demonstrated that Jaks and STATs
colonies are completely absent. However, multilin- are utilized by a variety of cytokine and growth factor
eage hematopoietic stem cells (CD34low, c-kitpos) can receptors (Watowich et al., 1996). To date, it is known
be found, and B lymphopoiesis appears intact. In con- that Jak2 is associated with receptors binding to the
trast to IFNa stimulation, Jak22/2 cells do not respond following factors: erythropoietin (Epo) (Witthuhn et al.,
to IFNg. Jak22/2 embryonic stem cells are competent 1993), growth hormone (GH) (Argetsinger et al., 1993),
for LIF signaling. The data provided demonstrate that thrombopoietin (Tpo) (Drachman et al., 1995, 1997),
Jak2 has pivotal functions for signal transduction of and, furthermore, common b chain±containing recep-
a set of cytokine receptors required in definitive eryth- tors binding granulocyte/macrophage colony-stimulat-
ropoiesis. ing factor (GM-CSF) (Quelle et al., 1994), interleukin-3
(IL-3) (Silvennoinen et al., 1993b), and IL-5 (Pazdrak et
al., 1995). Other receptors associated with Jak2 are
Introduction cardiotrophin-receptor (CT-R) (Pennica et al., 1995),pro-
lactin-receptor (PRL-R) (Campbell et al., 1994), granulo-
Cytokines are critical regulators for differentiation and cyte CSF-R (G-CSF-R) (Shimoda et al., 1994), and cyto-
proliferation of a variety of cells (Paul and Seder, 1994). kine receptors containing gp130 in their receptor chain
complex (IL-6-R, CNTF-R, LIF-R, and OSM-R) (for re-
view, O'Shea, 1997).# To whom correspondence should be addressed.
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Figure 1. Targeted Disruption of the Murine
Jak2 Gene
(A) The 59 part of the murine Jak2 gene and
relevant restriction sites are depicted at the
top. The targeting vector was designed to
replace part of the first coding exon and part
of the following intron by a pMC1neopA cas-
sette. The putative translation start site was
deleted, but the 59 splice accepter site was
kept intact. Location of probes for hybridiza-
tion and primers for screening PCR of ES cells
are indicated. For Southern blot analysis,
DNA was digested with HincII. The expected
fragment size after hybridization with the
flanking probe (probe A) is approximately 2
kb for the wild-type and approximately 4 kb
for the targeted allele. After hybridization of
the same blot with a neo-probe (probe B), an
approximately 4 kb signal is expected. Hc,
HincII; X, XbaI; and EI, EcoRI.
(B) Screening PCR of targeted ES cell clones.
Genomic DNA of ES cells was used in a PCR
with primers a and c (see Figure 1A and Ex-
perimental Procedures). Lane 1, Jak21/1 con-
trol; lane 2, targeted Jak21/2 ES cell clone 24;
lane 3, targeted Jak21/2 ES cell clone 72; lane
4, Jak22/2 ES cell clone 8; and lane 5, Jak22/2
ES cell clone 22. M, marker (l-phage DNA
cut with HindIII and EcoRI).
(C) Southern blot analysis of Jak2-targeted
ES cells. Hybridization with flanking probe
(probe A). Lane 1, Jak21/1 control; lane 2,
targeted Jak21/2 ES cell clone 24; lane 3, tar-
geted Jak21/2 ES cellclone 72; lane 4, Jak22/2
ES cell clone 8; and lane 5, Jak22/2 ES cell
clone 22. The sizes for the wild-type allele
(2 kb) and for the targeted allele (4 kb) are
indicated.
(D) Southern blot analysis of Jak2-targeted
ES cells. Stripped blot from (C) was rehybrid-
ized with neo-probe (probe B). One specific
integration is detected.
(E) Screening PCR after germline transmis-
sion of the Jak2 mutation. Genomic DNA from
tail clips was used in a PCR with primers a
and c. Lane 1, Jak21/1 control; lanes 2±5, tail
DNA from mice 55, 58, 59, and 62; lane 6, Jak22/2 ES cell control. M, marker.
(F) Southern blot analysis after germline transmission of the Jak2 mutation. Hybridization with flanking probe (probe A). Lane 1, Jak21/1
control; lanes 2 and 3, tail DNA from mouse 55 and 58.
(G) Rehybridization of blot (F) with neo-probe.
Epo-R, Tpo-R, GM-CSF-R, and IL-3R play an impor- with YS-derived cells undergoing primitive erythropoi-
esis, whereas intraembryonic precursors give rise totant role in controlling the differentiation of hematopoi-
etic stem cells (HSCs) (Emerson et al., 1985; Morrison definitive hematopoiesis after day 12 p.c. (Cumano et
al., 1996).et al., 1995). Starting at day 7.5 postcoitum (p.c.) of
murine ontogeny, hematopoiesis takes place in the yolk The erythroid lineage has at least two separate classes
of progenitor cells: the erythroid burst-forming unitsac (YS) (Moore and Metcalf, 1970), followed by he-
matopoiesis in the paraaortic splanchnopleura/aorta- (BFU-E), which is a more primitive progenitor cell, and
the more differentiated erythroid colony-forming unitgonads-mesonephros region (P-Sp/AGM) (Godin et al.,
1993; Medvinsky et al., 1993; MuÈ ller et al., 1994). (CFU-E) (Gregoryand Eaves, 1978). The earliestmorpho-
logically definable precursor cell of the erythroid lineageOnly hematopoietic cells derived from the P-Sp/AGM
region give rise to definitive hematopoiesis (Cumano et is the proerythroblast,which develops from CFU-E (Met-
calf, 1989). In Epo and Epo-R2/2 mice, a block in defini-al., 1996). After establishment of systemic circulation in
the embryo at day 9 p.c., HSCs contributing to definitive tive erythropoiesis was revealed, leading to embryonic
lethality at day 13 p.c., caused by a severe anemia (Wuhematopoiesis are simultaneously present in the YS and
P-Sp/AGM during preliver stage of hematopoiesis (Yoder et al., 1995).
To elucidate the in vivo function of Jak2, a mouseet al., 1997). Starting on day 10 p.c., cells from both




Disruption of the Murine Jak2 Gene
A replacement-type targeting vector pJak2 that contains
a 1 kb short arm and a 3.8 kb long arm of homolog
sequences was constructed. For positive selection, a
pMC1neopA-cassette was inserted in antisense, and a
HSV-tk-cassette was added for negative selection (see
Experimental Procedures). The splice accepter site of
the first coding exon was retained, whereas the start
codon and the remaining part of the exon were deleted
in the targeting vector to ensure that no Jak2 protein
was produced from the mutant allele (Figure 1A). After
electroporation and drug selection, double-resistant
colonies of ES cells were picked. Screening PCR was
performed using a primer outside of the construct and
a primer hybridizing to the neor-cassette. PCR products
were separated on an agarose gel, blotted, and hybrid-
ized with the short arm of the construct. Southern blot
analysis was performed after HincII digestion and hy-
bridization with an external probe from the 59-flanking
region (Figure 1C, probe A).The expected 4 kb hybridiza-
tion signal, corresponding to the targeted allele, wasFigure 2. Embryonic Lethality of the Jak2 Inactivation
detected in about 13% of ES cell clones. Afterward,(A) Screening PCR of embryos at day 11.5 p.c. Genomic DNA of
explanted embryos was used in a PCR with primers a and c (see the filters were stripped and reprobed with part of the
Figure 1 and Experimental Procedures). Lane 1, Jak22/2 ES cell neomycin-resistance gene cDNA; only a single integra-
control; lane 2, Jak22/2 embryo; lane 3, Jak21/2 embryo; lane 4, tion was detectable (Figure 1D, probe B). Two indepen-
Jak21/1 embryo; and lane 5, Jak21/1 control. M, marker.
dently isolated and correctly targeted ES cell clones (24(B) Southern blot analysis of EF cells. Hybridization with flanking
and 72) were used for generating mutant mice.probe (probe A). Lane 1, Jak21/1 control; lane 2, Jak22/2 EF cells;
lane 3, Jak21/2 EF cells; and lane 4, Jak21/1 EF cells. For explanation
of hybridization signal, please refer to Figure 1.
(C) Immunoprecipitation of Jak2 protein from EF cells. Jak2 was Jak22/2 Mice Die during Midgestation
immunoprecipitated from cell homogenates and detected on West-
The correctly targeted ES cell clones were aggregatedern blots employing anti-Jak2 antibodies. In our hands, the back-
with CD1 morulae or injected into C57BL/6 blastocysts.ground of the Western blots (especially the band of z97 kDa) was
The resulting chimeric mice were backcrossed, andgreatly reduced by preclearing the cell homogenates (see Experi-
mental Procedures). Preclear: mixture of rabbit preimmune serum, germline transmission of the mutant allele was verified
anti-Jak1, and anti-Jak3 antibodies. Lane 1: g2A, negative control; by PCR and Southern blot analysis of tail DNA from F1
lanes 2 and 3: 2C4, positive control; lanes 4 and 5: Jak21/1 EF cells;
offspring (Figures 1E, 1F, and 1G). Both ES cell cloneslanes 6 and 7: Jak21/2 EF cells; lanes 8 and 9: Jak22/2 EF cells.
transmitted the mutant Jak2 allele into the germline.
Heterozygous mice carrying the deletion of the Jak2targeting. Timed pregnancy studies revealed that Jak22/2
gene appeared normal, viable, and fertile.animals die between day 12 and 13 p.c. The lack of
Heterozygotes were then intercrossed. No living off-enucleated erythrocytes in mutant animals defines a
spring homozygous for the mutated Jak2 allele wasnonredundant function of Jak2 in definitive erythropoie-
found at 3 weeks of age. Thegenotype of viable offspringsis. Embryonic fibroblasts (EF) and embryonic stem (ES)
showed a Mendelian ratio typical for an embryonicallycells devoid of functional Jak2 reveal that Jak2 is indis-
lethal phenotype (1:2:0) (Table 1). Thus, it was assumedpensable for IFNg but not for IFNa and LIF signaling.
that a Jak22/2 mutation leads to embryonic lethality. Ex-Flow cytometry demonstrates the loss of c-kitnegTer-
amination of embryos at different stages of development119posCD44low progenitor cell populations in the FL of
Jak22/2 animals. revealed that Jak22/2 embryos died between day 12 and
Table 1. Embryonic Lethal Phenotype of Jak22/2 Animals
Genotypes of Living Offspring from Jak21/2 Breeding Pairs Genotypes of Embryos from Timed Pregnancies
ES cell clone Jak21/1 Jak21/2 Jak22/2 Stage Jak21/1 Jak21/2 Jak22/2
#24 11 16 0 E11.5 4 14 7
#72 3 10 0 E12.5 3 12 4
#72 7 10 0 E13.5 7 14 4
#24 5 11 0 E15.5 10 14 6a
Total 26 47 0 Total 24 54 21
a Embryos were almost completely resorbed in utero.
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Figure 3. Severe Anemia in Jak22/2 Mice
(A) Jak21/1 embryo (day 12.5 p.c.) inside the
YS. (B) Jak22/2 embryo (day 12.5 p.c.) inside
the YS.
(C) Jak21/1 embryo (day 12.5 p.c.). (D) Jak22/2
embryo (day 12.5 p.c.).
(E) Jak21/1 embryo (day 13.5 p.c.). (F) Jak22/2
embryo (day 13.5 p.c.).
(G) Body size comparison of Jak21/1 (left
side) and Jak22/2 embryos (right side) at day
12.5 p.c.
Original magnification for the Jak21/1 em-
bryos ([A], [C], and [E]) was 103, and original
magnification for Jak22/2 embryos ([B], [D],
and [F]) was 113.
13 p.c. At day 15 p.c., all Jak22/2 embryos were almost Jak2 Gene±Targeted Mice Do Not Produce
Jak2 Proteincompletely resorbed in the uterus. Genotyping showed
a normal Mendelian ratio (1:2:1) up to day 15 p.c. (Figure EF cells were obtained from E11.5, E12.5, and E13.5
animals. In accordance with results mentioned above,2A and Table 1). The phenotype observed was identical
in mouse lines derived from the two different ES cell no EF cell lines could be grown from Jak22/2 embryos
at day 15.5 p.c. The genotype of EF cell lines usedclones and the different genetic backgrounds, making
it unlikely that embryonic lethality resulted from a spon- for further investigation was determined by Southern
blotting (Figure 2B). EFs were analyzed for expressiontaneous mutation in an ES cell line. Thus, it was con-
cluded that Jak2 defines a critical checkpoint during of Jak2 protein (Figure 2C). To this end, Jak2 protein
was immunoprecipitated from cell homogenates andontogeny at day 12.5 p.c.
Jak2-Deficient Mice
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Table 2. Number of Nucleated Cells Per FL
E11.5 E12.5
Jak21/2 Jak22/2 Jak21/2 Jak22/2
2.6 3 105 6 1.3 3 105 0.8 3 105 6 0.24 3 105 35 3 105 6 9 3 105 1.6 3 105 6 0.9 3 105
(n 5 15) (n 5 6) (n 5 9) (n 5 6)
detected on Western blots employing anti-Jak2 antibod- were analyzed after Giemsa staining (Figure 5). As ex-
pected, cell preparations of Jak21/2 animals showed allies. For negative control, a mutagenized human fibrosar-
coma cell (y2A) was used that lacks Jak2 mRNA and stages of erythropoietic differentiation, including numer-
ous FL-derived enucleated erythrocytes and a few YS-protein (Kohlhuber et al., 1997). The parental cell line
2C4 was used for positive control (Watling et al., 1993). derived nucleated erythrocytes (Figures 5A and 5C).
Only proerythroblasts and very few nucleated erythro-In 2C4, in Jak21/1, and in Jak21/2 EF cells, a 130 kDa
Jak2 protein could readily be precipitated. In contrast, cytes were identifiable in preparations from Jak22/2 YS
and peripheral blood. Enucleated FL-derived erythro-inJak22/2 EFs, no Jak2protein was detectable.Based on
this result, it was concluded that Jak2 was successfully cytes could never be seen (Figures 5B and 5D). These
results suggest that Jak2 is essential for Epo-R signalinginactivated in the Jak22/2 embryos.
and definitive erythropoiesis in FL.
Definitive Erythropoiesis in Jak22/2 Fetal Liver
Is Completely Impaired Analysis of Hematopoietic Cell Populations
in Fetal LiverThe most dramatic morphological consequence of the
Jak2 inactivation turned out to be a severe anemia (Fig- Hematopoietic cell populations and differentiation stages
can be distinguished by expression of characteristicure 3). Due to the low number of circulating hemoglo-
binized cells, the embryos appeared pale. Additionally, markers such as CD34, CD44, c-kit, and Ter-119 (Ikuta
et al., 1990; Krause et al., 1994; Sanchez et al., 1996;the liver size of mutant embryos was dramatically re-
duced compared to that of normal littermates. The num- Aguila et al., 1997). Flow cytometry was performed to
verify the expression of these cell surface markers. Sin-ber of nucleated cells was reduced more than 10-fold
in the FL of Jak22/2 animals compared to that in the FL gle-cell suspensions of FL cells isolated from wild-type,
Jak22/2, or Epo-R2/2 embryos at day 12.5 p.c. were used.of littermates (Table 2). The typical red color of the FL
was not visible in Jak22/2 embryos (Figure 3F). No signifi- At this stage of embryonic development, CD34low and
CD34neg cells can be detected in FLs (Yoder et al., 1997).cant difference was observed between wild-type and
heterozygous littermates (data not shown). YS enclosing Three different cell populations with regard to CD44
expression can be distinguished in wild-type FL: CD44neg,homozygous embryos were of normal size, but YS ves-
sels contained only very few circulating erythrocytes CD44low, and CD44high. Interestingly, the proportion of
CD34lowCD44high cells was slightly increased in Epo-R2/2(Figure 3B).
Histological examination of tissue sections obtained mice, whereas CD34lowCD44high cells were markedly in-
creased in Jak22/2 FL (Figure 6). While in control FL,from wild-type, Jak22/2, and Epo-R2/2 embryos at day
12.5 p.c. allowed a comparison of circulating hemoglo- CD44low cells constitute the majority of cells, in Epo-R2/2
and in Jak22/2 FL, CD44high-expressing cells are predomi-binized cells and erythropoietic foci in FL (Figure 4).
Embryo sections revealed a tremendous reduction of nant (Figure 6). A similar staining pattern could be ob-
tained with c-kit. Here again, c-kitneg cells constitutedcirculating nucleated erythrocytes in blood vessels of
Jak22/2 embryos. Peripheral blood vessels of Epo-R2/2 the majority of cells in control FL, whereas in Epo-R2/2
and Jak22/2 FLs, c-kitpos cells appeared to be predomi-embryos still contained substantial numbers of nucle-
ated erythrocytes. Jak22/2 FLs contained only very few nant. Labeling with Ter-119, expressed on precursors
of erythropoiesis after the CFU-E stage, indicated thaterythropoietic foci within the parenchym (Figure 4H). In
comparison, erythropoietic islands were numerous in the reduction of CD44low cells in Jak22/2 FLs can be
attributed to a lack of Ter-119pos cells. Interestingly, athe liver of wild-type animals (Figure 4G). In wild-type
FL, erythroid cells of all stages of differentiation could small population of Ter-119posCD44neg primitive erythroid
cells can be detected in control and Jak22/2 FLs. Thesebe seen. In contrast, in Jak22/2 and Epo-R2/2 FLs, almost
no erythroid cells were visible (Figures 4H and 4I). All data provide evidence that definitive erythropoiesis is
defective in Jak22/2 animals. However, the populationtissue sections from wild-type embryos contained many
YS-derived primitive erythrocytes, whereas very few harboring the long-term reconstituting HSCs, coex-
pressing CD34 and c-kit, is present in Jak22/2 mice.ones were visible in the FL of both mutant embryos.
Furthermore, wild-type animals contained FL-derived
enucleated erythrocytes originating from definitive eryth- Blocked Hemoglobinization of Erythroid Cells
in Jak22/2 Embryosropoiesis. In contrast, in Jak2 and Epo-R mutant em-
bryos, enucleated erythrocytes could never be discov- To determine at which stage during erythropoiesis Jak2
plays a crucial role, in vitro colony assays of erythroidered. Thus, it appears that in the absence of Jak2,
definitive erythropoiesis is blocked. progenitors were performed (Cumano et al., 1996). FL
cells from wild-type, Jak22/2, and Epo-R2/2 animals wereTo confirm these results, cytospin preparations of pe-
ripheral blood and YS of normal and mutant embryos incubated in methylcellulose supplemented with IL-3,
Cell
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Figure 4. Histology of Wild-Type, Jak22/2, and Epo-R2/2 Embryos
Hematoxylin- and eosin-stained longitudinal tissue paraffine sections of E12.5 embryos. (A) Low (503), (D) middle (1003), and (G) high (2003)
power magnification of sections of wild-type embryos. FL is of normal size, high hematopoietic activity; many nucleated and enucleated
erythrocytes are visible.
(B) Low, (E) middle, and (H) high power magnification of sections of Jak22/2 embryos: FL is very small, almost no hematopoietic activity, only
few nucleated erythrocytes, and no enucleated erythrocytes are visible.
(C) Low, (F) middle and (I) high power magnification of sections of Epo-R2/2 embryos: FL is small, almost no hematopoietic activity, and
reduced numbers of nucleated erythrocytes are visible. FH, fetal heart; arrowheads depict erythropoietic foci.
SCF, GM-CSF, and Epo. After incubation, BFU-Es and erythropoiesis. Interestingly, B lymphopoiesis appears
intact in the absence of Jak2 (Table 3).CFU-Es were counted (Tables 3 and 4). In Jak22/2 FL
cell cultures, the number of BFU-E and CFU-E colonies
was below the detection limit of the assay. In contrast IFN-R and LIF-R Signaling in the Absence of Jak2
Jak2 is constitutively associated with the IFNg-R b chainto Jak22/2 FL cell cultures, colonies were readily de-
tected in Epo-R2/2 FL cell cultures. However, their num- (Kotenko et al., 1995; Bach et al., 1996). Conflicting data
about the association of Jak2 with gp130 was reportedber was about 10-fold reduced compared to that of FL
cell cultures of wild-type embryos. Part of the FL cells (Narazaki et al., 1994; Stahl et al., 1994; Guschin et al.,
1995). To address the functional role of Jak2, EFs werewas incubated in a liquid culture with S17 stromal cells,
IL-3, SCF, GM-CSF, and Epo for 5 days. Then, benzidine stimulated with IFNa or IFNg, and, subsequently, IFNa-
responsive (IRF-1) as well as IFNg-responsive genesstaining was performed, and hemoglobin-containing
cells were scored. In Jak22/2 FL cell cultures, almost no (IRF-1, GBP-2) were monitored. For LIF signaling via
gp130, homozygously targeted Jak22/2 ES cells werebenzidine-positive cells were detected. In Epo-R2/2 FL
cell cultures, about 23% of the cells were benzidine used (see Experimental Procedures). As indicated by
Northern blot analysis, up-regulation of IRF-1 could bepositive, which was less than half of the amount of wild-
type controls. These data suggest that erythropoiesis readily verified in Jak21/2 as well as in Jak22/2 EFs after
IFNa stimulation (Figure 7B). In marked contrast, IFNgis more severely blocked in Jak22/2 mice than in Epo-R2/2
mice and indicate that Jak2 is indispensible for definitive stimulation did not result in induction of IRF-1 or GBP-2
Jak2-Deficient Mice
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Figure 5. Cytospin Preparations of YS and Fetal Blood
(A) YS and (C) peripheral blood cytospin preparations from a representative Jak21/2 E12.5 embryo after Giemsa staining. Numerous erythropoi-
etic cells in all stages of differentiation are present, including proerythroblasts (E), basophilic erythroblasts (Bs), polychromatic erythroblasts
(P), orthochromatic erythroblasts (O), and enucleated erythrocytes (N). YS-derived nucleated erythrocytes are visible as well (Y).
(B) YS and (D) peripheral blood cytospin preparations from a representative Jak22/2 E12.5 embryo after Giemsa staining. Proerythroblasts (E)
are found. Very rarely, nucleated erythrocytes from the YS are observed (Y); no enucleated erythrocytes were detectable.
in Jak22/2 EFs, whereas in control cell lines, IRF-1 and al., 1995; Briscoe et al., 1996). To detect the biological
role of Jak2, a gene-targeted mouse strain was estab-GBP-2 were readily transcribed (Figure 7A). These re-
sults indicate that signaling via type II IFN-R, but not lished. Jak22/2 mice reveal that Jak2 plays an important
role in definitive erythropoiesis. Definitive erythropoie-via type I IFN-R, is essentially dependent on Jak2.
To examine the involvement of Jak2 in signaling via sis is disrupted at the differentiation to the acidophilic
erythroblast. Embryos die between day 12 and dayLIF-R, Jak21/1 and Jak22/2 ES cells were grown for 4
days without an EF cell layer and in the absence of 13 p.c. probably due to severe anemia. This phenotype
of Jak22/2 mice appears to be comparable to EpoLIF. Then, LIF-containing medium was added, and up-
regulation of IRF-1 was analyzed. Induction of IRF-1 and Epo-R2/2 animals. However, clear differences were
found: Jak22/2 embryos contained fewer circulatingmRNA could readily be detected in Jak21/1 and in
Jak22/2 ES cells (Figure 7C), indicating that Jak2 is not primitive erythrocytes, and almost no benzidine-positive
erythroid colonies were detectable in BFU-E and CFU-Einvolved in the LIF-R/gp130 signal cascade. Further evi-
dence along this line is provided by the observation that assays. This indicates that the defect in Jak22/2 em-
bryos is more severe than that in Epo-R2/2 embryos,Jak22/2 ES cells do not differentiate in LIF-containing
medium after long-term culture (data not shown). leading to the conclusion that Epo-R signaling is not the
only deficiency inJak22/2 mice. Besides the Epo-R, Jak2
is associated with the IL-3-R, GM-CSF-R, and Tpo-R.
Mice deficient in bIL-3 (Nishinakamura et al., 1995), com-Discussion
mon b chain (bc) (Nishinakamura et al., 1995), GM-CSF
(Dranoff et al., 1994), and IL-5 (Kopf et al., 1996) demon-Since the original description of Jak2 involvement in
Epo-R and IFNg-R signaling (Watling et al., 1993; Witt- strated that IL-3, GM-CSF, and IL-5 are not crucial for
hematopoiesis. Tpo2/2 mice contain fewer thrombo-huhn et al., 1993), it has become clear that Jak2 par-
ticipates in signal transduction of a variety of cytokine cytes due to a reduced differentiation of megacaryo-
cytes but show normal levels of other hematopoieticand growth factor receptors (Darnell et al., 1994; Ihle et
Cell
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Figure 6. Flow Cytometry of Hematopoietic Cells in the FL of Day 12.5 p.c. Mouse Embryos
The cell surface expression of different markers is depicted. Cell suspensions from day 12.5 p.c. FL were labeled with anti-c-kit, anti-CD44,
anti-Ter-119, or anti-CD34 antibodies. Representative results from 1 out of 5 embryos are shown. Eight thousand live events are gated.
cell types (Gurney et al., 1994). In stem cell assays, Tpo, that Epo, IL-3, GM-CSF, and SCF are at least partially
redundant due to their capacity of Jak2 activation.especially in combination with SCF and/or IL-3, acts
synergistically on the propagation of multiple types of The defects of Jak22/2 embryos are also distinct from
other mouse mutations affecting hematopoiesis. GATA-hematopoietic colonies, including multilineage colonies
from a highly purified population of hematopoietic pro- 22/2 embryos die at E10-E11 with severe anemia due to
an impairment of both primitive and definitive erythro-genitors (Kobayashi et al., 1996; Ku et al., 1996; Yoshida
et al., 1997). The lack of BFU-E and CFU-E colonies in poiesis (Tsai et al., 1994). At this point of embryonic
development, Jak22/2 embryos are vital but anemic.Jak22/2 FL cell cultures and the presence of BFU-E and
CFU-E colonies in Epo-R2/2 FL cell cultures indicate that Mice deficient in c-myb and the retinoblastoma gene
(Rb2/2) die at E15-16 exhibiting anemia (Mucenski et al.,the lack of Epo-R signaling at this stage of erythropoiesis
might, at least partially, be overcome by IL-3-R and GM- 1991; Clarke et al., 1992). Mice with a c-myb deficiency
appear normal at day 13 of gestation, suggesting thatCSF-R signaling via Jak2.
Mice lacking SCF (Sl mutant) or its receptor c-kit (W c-myb is not essential for early development. The eryth-
ropoietic defect seen in Rb2/2 mice seems to be partlymutant) exhibit a significant reduction of CFU-E in the
FL (Nocka et al., 1989). Conflicting evidence is provided due to abnormalities in the hemopoietic microenviron-
ment of FLs where hepatocytes undergo apoptosis.on Jak2 involvement in c-kit signaling (Tang et al., 1994;
Weiler et al., 1996; Deberry et al., 1997). Thus, at the Gp1302/2 mice die between day 12.5 p.c. and day 20
p.c., and some of the mutant embryos show a severecurrent stage of investigation, it might be suggested
that the severe defect in Jak22/2 erythropoiesis is addi- anemia (Yoshida et al., 1996). Gp1302/2 embryos show a
hypoplastic ventricular myocardium. In Jak22/2 animals,tionally caused by a lack of SCF signaling. Taken to-
gether, at this early stage of hematopoiesis it appears the heart is enlarged. This heart alteration might be a
Table 3. Number of BFU-E Progenitors and B-Lymphocyte Precursors in Jak22/2 and Epo-R2/2 Embryos
BFU-E Assay (Day 7) B-Lymphocyte Precursors
Wild-Type Jak22/2 Epo-R2/2 Wild-Type Jak22/2 Epo-R2/2
5250 6 250 ,10 550 6 50 771 6 130 355 6 168 540
(n 5 3) (n 5 2) (n 5 2) (n 5 4) (n 5 5) (n 5 1)
Number of colonies per FL.
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Table 4. Number of CFU-E in Jak22/2 and Epo-R2/2 Embryos
CFU-E Assaya (Day 3) CFU-E Assayb (Day 5)
Jak21/2 Jak22/2 Epo-R1/2 Epo-R2/2 Jak21/2 Jak22/2 Epo-R1/2 Epo-R2/2
CFU-E 230 6 10 ,10 310 6 10 105 6 15
(absolute count) (n 5 2) (n 5 4) (n 5 2) (n 5 3)
Benzidine-positive 46.5 6 1.5 1 6 0 47 6 1 23 6 6
cells (%) (n 5 2) (n 5 4) (n 5 2) (n 5 3)
CFU-E (per FL) 2.3 3 104 ,200 3.1 3 104 2.1 3 103
a 1:10 (ko animals) or 1:50 (wild-type animals) of the FL was used for 2 ml of methylcellulose mixture with (2 ng/ml) rIL-3, rSCF, rGM-CSF, and
human rEpo (4 U/ml). The numbers reflect independent counts done on the 2 ml plated in 35 mm dishes with 1 ml each of the original mixture.
The choice of amount of cells was based on the fact that ko mice had about 103 fewer cells than controls. SCF and IL-3 were obtained from
the supernatant of cells transfected with the cDNA encoding the respective genes. They were titrated on the capacity to grow FL cells and
generate mast cells efficiently.
b FL cells were plated in liquid culture with S17 stromal cells, rIL-3, rEpo, rSCF, and rGM-CSF at the same concentrations. On day 5 of culture,
benzidine staining was performed, and hemoglobin-containing cells were counted. Numbers indicate percentages of benzidine-positive cells
per total number of cells.
secondary effect due to hypoxemia. This finding, to- expected, that IFNg-R signals were disrupted, whereas
signaling via type I IFN-R, which uses Jak1 and tyk2,gether with the induction of IRF-1 by LIF in homozy-
gously targeted ES cells, further suggests that gp130/ remained intact. It might be speculated that RAG/Jak2
chimeras generated from homozygous Jak22/2 ES cellsLIFRb signaling is not mediated via Jak2.
PU.12/2 embryos die at a late gestational stage (E16- might have defective Th1 responses due to the absence
of IFNg-R as well as IL-12-R signaling (Briscoe et al.,18), and anemia starts at E14.5 with variable severity
(Scott et al., 1994). AML12/2 embryos reveal intact he- 1996; Chen, 1996).
The results observed with Jak22/2 ES cells clarifiesmatopoiesis in the primitive YS but are completely defi-
cient in FL hematopoiesis. The AML12/2 embryos die the involvement of Jak2 in LIF-Rb/gp130 signaling.
Long-term culture of Jak22/2 ES cells did not lead toaround day 12.5 p.c. from multiple bleeding probably
due to an absence of circulating platelets (Okuda et al., differentiation, and LIF stimulation readily triggered up-
regulation of IRF-1, indicating that the LIF-Rb/gp1301996).
According to recently established models (Cumano signaling complex is not dependent on Jak2.
In summary, the defects in Jak22/2 mice are moreet al., 1996; Sanchez et al., 1996; Yoder et al., 1997),
multipotent HSC, which are able for long-term reconsti- profound than these in Epo-R2/2 mice (Wu et al., 1995)
and only partially overlapping with defects encounteredtution (LTR) of conditioned newborn recipients, arise in
the YS and P-Sp/AGM region. Reconstitution potential in Jak12/2 mice (Rodig et al., 1998 [this issue of Cell]).
Jak2 functions are crucial in control for erythroid/my-of multilineage progenitors in conditioned adult recipi-
ents is first found in the AGM atday 10p.c., then followed eloid lineage differentiation but appear not to be essen-
tial for the lymphoid lineage, as in vitro differentiationon day 11 p.c. by FL and YS (MuÈ ller et al., 1994). Recon-
stitution experiments showed that LTR-HSCs in the of B lymphocytes (this study) as well as lymphoid recon-
stitution of Jak32/2 mice with Jak22/2 FL cells (ParganasAGM and FL are exclusively in the c-kitposCD34low frac-
tion, which may arise from the c-kitposCD34neg population et al., 1998 [this issue of Cell]) is possible. The Jak2
absence defines a genetic checkpoint at the transition(Krause et al., 1994; Sanchez et al., 1996; Aguila et al.,
1997). Interestingly, c-kitposCD34low LTR-HSC cells are from primitive to definitve erythropoiesis. Additional stud-
ies with conditional inactivation of Jak2 are required tostill present in Jak22/2 mice, and precursors for B lym-
phocytes could be differentiated under suitable culture bypass the embryonic lethality and to define the role of
this important kinase in an adult organism.conditions, indicating that the lymphocytic lineage, in
contrast to the differentiation of erythroid/myeloid lin-
eage, is not dependent on Jak2. At day 12.5 p.c., almost
Experimental Procedures
all c-kitneg cells express the erythroid Ter-119 marker
(Ikuta et al., 1990). In Jak22/2 FLs, c-kitnegTer-119pos cells Generation of Jak22/2 Mice
A genomic library (129/Sv/lDash2) was screened with a partial Jak2were dramatically reduced at day 12 p.c., indicating that
cDNA clone. A genomic clone containing the first coding exon waserythroid differentiation is severely blocked. Interest-
isolated, mapped, and partially sequenced (data not shown). Theingly, some c-kitnegTer-119pos cells were still present in
sequenced exon was identical to the corresponding region of theJak22/2 FLs. These cells might represent cells derived
published cDNA (Silvennoinen et al., 1993b; GeneBank accession
from fetal erythropoiesis having immigrated from the YS. number L16956). The targeting vector pJak2 was constructed by
Since erythropoiesis in Jak22/2 animals is more severely inserting a 1 kb XbaI-XbaI fragment encoding part of the 59 intron
and the 59 part of the coding exon into pBlue (Stratagene) yieldingblocked than in Epo-R2/2 mice, it seems unlikely that
pJak2-X4. Then, a 1.1 kb BamHI-XhoI fragment from pMC1neopolyAc-kitnegTer-119pos cells represent early nucleated erythro-
(Stratagene) containing a neomycin resistance cassette was in-blasts from definitive erythropoiesis. Thus, it is sug-
serted in antisense into the SmaI site of pJak2-X4, yielding pJak2-gested that erythropoietic stem cells are arrested in
X4neopA. Next, a 3.8 kb downstream HincII fragment was cloned
Jak22/2 embryos at a CD44highc-kitposTer-119neg stage. into the EcoRV site of pJak2-X4neopA, yielding pJak2-X4neopAE1.
Experiments addressing the signaling capacity of cy- Finally, a 2.7 kb herpes simplex virus thymidine kinase (HSV-tk)
cassette (XhoI-SalI-SspI digest/pGEM7[TK]) was inserted into thetokine receptors in the absence of Jak2 revealed, as
Cell
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Homozygous Mutant ES Cell Lines
To generate homozygous mutant ES cell lines, Jak21/2 ES cells were
incubated in the presence of 1.6 mg/ml G418 (Mortensen et al.,
1992). Surviving colonies were assayed for loss of the wild-type
allele, and Jak22/2 ES cells were subcloned.
Cell Culture
ES cells were grown in DMEM medium (GIBCO-BRL) supplemented
with L-glutamin (2 mM, Seromed), leukemia inhibitory factor, Pen/
Strep (100 mg/ml, Seromed), 2-ME (0.05 mM, GIBCO-BRL), and FCS
(15%, GIBCO-BRL).
Mouse EF cells were prepared from individual 11- to 13-day-
old embryos as described (Wurst and Joyner, 1993). EF cells were
cultivated in DMEM medium as above, except 5% FCS was used.
RNA Isolation and Northern Blot Analysis
Mouse EF cells were stimulated with murine rIFNg (10 ng/ml, Gen-
zyme) or murine rIFNa (1000 IRU/ml, BIOSOURCE) for 19 or 6 hr,
respectively. Mouse ES cells were deprived of LIF for 4 days and
then stimulated with LIF for 1 hr. Cells were lysed in 2 ml lysis buffer
consisting of 4 M guanidinium isothiocyanate (Merck), 0,5% (w/v)
N-lauryl-sarcosine (Serva), 15 mM Na-citrate (pH 7.0), and 100 mM
2-ME (Sigma). Total RNA was prepared as described (Chomczynski
and Sacchi, 1987). Twenty micrograms total RNA was fractionated
on formaldehyde agarose gels, blotted onto GeneScreen Plus mem-
brane (Biotechnology Systems), and hybridized with fluorescein- or
32P-labeled cDNA probes (Amersham). The following partial murine
cDNA probes were used: interferon regulatory factor-1 (IRF-1, 550
bp) and guanylate binding protein-2 (GBP-2, 800 bp) (FuÈ tterer et al.,
unpublished data). Methylene blue staining or hybridization with
murine GAPDH cDNA (1150 bp) was performed as loading control.
Histological Analysis of Embryos
Embryos weredissected and genotyped. For histology, the embryos
were fixed in 10% buffered formalin for 24±48 hr and embedded in
paraffine. Sections (5 mm) were stained with hematoxylin and eo-
Figure 7. Response of Jak22/2 Cells to IFNg, IFNa, and LIF sin (HE).
(A) Northern blot of EF cells after treatment with medium alone (2)
or with 10 ng/ml IFNg for 19 hr (g). Lanes 1 and 2: Ana-1 cells, Cytospins, BFU, and CFU Assays
positive control; lanes 3 and 4: Jak21/1 EF cells; lanes 5 and 6: YS cells and peripheral blood were prepared by cytospin technique
Jak21/2 EF cells; lanes 7 and 8: Jak22/2 EF cells. Hybridization with and stained according to May-GruÈ nwald. Colony assays were per-
GBP-2 (upper panel) and IRF-1 (middle panel). The lower panel formed as described (Cumano et al., 1996). For analysis of erythroid
shows the methylene blue±stained 18S rRNA band as a loading differentiation stages, FL cells were grown in methylcellulose con-
control. taining a mixture of rIL-3, rSCF, rGM-CSF (2 ng/ml), and human
(B) Northern blot of EF cells after treatment with medium alone (2), rEpo (4 U/ml). Suspension cells were transferred to glass slides by
with 1000 U/ml IFNa for 6 hr (a), or with 10 ng/ml IFNg for 19 hr (g). cytospin technique at day 5 of culture and stained with benzidine
Lane 1: Jak21/2 EF cells, unstimulated; lane 2: Jak21/2 EF cells, (Sigma). Briefly, cells were washed in PBS and resuspended in equal
IFNa stimulated; lane 3: Jak21/2 EF cells, IFNg stimulated; lane volumes of PBS and benzidine/H2O2 for 15 min. After several washes
4: Jak22/2 EF cells, unstimulated; lane 5: Jak22/2 EF cells, IFNa with PBS, cells were scored under a microscope.
stimulated; lane 6: Jak22/2 EF cells, IFNg stimulated. Note that in
(A) and (B) two independent experiments are shown where basal B-Lymphoid Conditions
IRF-1 transcription in EF cells slightly varied. Cells were cultured on S17 stromal cells with medium supplemented
(C) Northern blot of ES cells after treatment with LIF. ES cells were with rIL-7 and rSCF. Cells were counted by microscopical scoring
deprived of LIF for 4 days and then incubated with LIF for 1 hr. (Cumano et al., 1993).
Lane 1: Jak21/1 ES cells deprived of LIF; lane 2: Jak21/1 ES cells
stimulated with LIF; lane 3: Jak22/2 ES cells deprived of LIF; lane Immunoprecipitation and Western Blot Analysis
4: Jak22/2 ES cells stimulated with LIF. 1 3 107 cells were lysed in a lysis buffer containing 0.5% NP-40
(ICN Biomedicals), 50 mM Tris/Cl (pH 8.0) (Sigma), 10% glycerol
(Sigma), 0,1 mM EDTA, 200 mM NaCl (Sigma), 0,1 mM Na3VO4SalI site of pJak2-X4neopAE1 generating the pJak2 targeting vector.
(Sigma), 1 mM DTT (Sigma), 0,4 mM PMSF, 3 mg/ml aprotinin, 2 mg/The NotI-linearized pJak2 was electroporated into E14.1 ES cells
ml pepstatin, 1 mg/ml leupeptin, and 2 mg/ml bestatin (all Boeh-(129/Sv/J), and transfected cells were cultivated in the presence of
ringer). The lysates were precleared with protein A-SepharoseG418 (0.2 mg/ml) and gancyclovir (2 mM) as described (Wurst and
(Sigma) and a mixture of rabbit preimmune serum, rabbit anti-mouseJoyner, 1993). Double resistant cells were screened for homologous
Jak1 (Wilks et al., 1991), and rabbit anti-mouse Jak3 polyclonal serarecombination. For PCR screening, the following primers were used:
(Upstate Biotechnology). After preclearing, lysates were precipi-KO1 (59-GCCATGCCCAAGTTGTAACTC-39) annealing upstream of
tated with a rabbit anti-mouse Jak2 polyclonal serum (specific forthe targeting construct and neo1500 (59-TCGCCTTCTATCGCCTTC
aa 758-776, Upstate Biotechnology) and loaded on an 8% SDSTTG-39) annealing in the neomycin resistance cassette. As flanking
polyacrylamide gel. The gel was semi-dry blotted on nitrocelluloseprobe (probe A) a 1 kb EcoRI fragment was used. The neo-probe was
(Protran BA 85, Schleicher and Schuell/BIORAD, Trans-Blot SD).from pMC1neopolyA. Two ES cell clones containing the correctly
Western detection was performed with a rabbit anti-mouse JH2-targeted Jak2 allele were both aggregated with CD1 morulae or
Jak2 polyclonal serum (A. Ziemiecki, unpublished data) followed byinjected into C57BL/6 blastocysts. Chimeric mice were backcrossed
incubation with mouse anti-rabbit AP-coupled antibody and detec-to CD1 or C57BL/6 mice, and germline transmission of the mutant
allele was confirmed by PCR and Southern blot analysis. tion by ECL kit (Amersham).
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Flow Cytometry Darnell, J.E., Jr., Kerr, I.M., and Stark, G.R. (1994). Jak-STAT path-
ways and transcriptional activation in response to IFNs and otherEmbryos were explanted at day 12.5 p.c. FLs were isolated, and a
extracellular signaling proteins. Science 264, 1415±1421.single-cell suspension was obtained. The cell suspensions were
incubated on ice with rat anti-mouse CD16/CD32 (Pharmingen) to Deberry, C., Mou, S., and Linnekin, D. (1997). Stat1 associates with
block Fc receptor binding. Cells were incubated with rat anti-mouse c-kit and is activated in response to stem cell factor. Biochem. J.
biotin-conjugated CD34 (clone RAM34)/streptavidin-phycoerythrin 327, 73±80.
(PE), fluorescein isothiocyanate (FITC)±conjugated anti CD44, FITC- Drachman, J.G., Griffin, J.D., and Kaushansky, K. (1995). The c-Mpl
conjugated anti c-kit, anti Ter-119-PE, or appropriate isotype control ligand (thrombopoietin) stimulates tyrosine phosphorylation of Jak2,
antibodies (all Pharmingen) on ice. Subsequently, cells werewashed Shc, and c-Mpl. J. Biol. Chem. 270, 4979±4982.
and transferred to PBS 1% PFA. For flow cytometry a Coulter Epics
Drachman, J.G., Sabath, D.F., Fox, N.E., and Kaushansky, K. (1997).XL cytometer was used.
Thrombopoietin signal transduction in purified murine megakaryo-
cytes. Blood 89, 483±492.
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